Andrew Rauth
Andrew Rauth
Professor Emeritus Medical Biophysics, University of Toronto
uhnres.utoronto.ca üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles
HL Wong, R Bendayan, AM Rauth, Y Li, XY Wu
Advanced drug delivery reviews 59 (6), 491-504, 2007
5972007
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system
HL Wong, R Bendayan, AM Rauth, HY Xue, K Babakhanian, XY Wu
Journal of Pharmacology and Experimental Therapeutics 317 (3), 1372-1381, 2006
3952006
Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and …
P Prasad, CR Gordijo, AZ Abbasi, A Maeda, A Ip, AM Rauth, RS DaCosta, ...
ACS nano 8 (4), 3202-3212, 2014
3522014
A new polymer–lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells
HL Wong, AM Rauth, R Bendayan, JL Manias, M Ramaswamy, Z Liu, ...
Pharmaceutical research 23 (7), 1574-1585, 2006
3422006
Evidence for dark-reactivation of ultraviolet light damage in mouse L cells
AM Rauth
Radiation research 31 (1), 121-138, 1967
2591967
Principles and applications of ultrasound backscatter microscopy
FS Foster, GR Lockwood, LK Ryan, KA Harasiewicz, L Berube, AM Rauth
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 40 …, 1993
2501993
Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells
JK Mohindra, AM Rauth
Cancer research 36 (3), 930-936, 1976
2251976
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer
HL Wong, R Bendayan, AM Rauth, XY Wu
Journal of controlled release 116 (3), 275-284, 2006
2122006
Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers
HL Wong, R Bendayan, AM Rauth, XY Wu
Journal of pharmaceutical sciences 93 (8), 1993-2008, 2004
1972004
The physical state of viral nucleic acid and the sensitivity of viruses to ultraviolet light
AM Rauth
Biophysical Journal 5 (3), 257-273, 1965
1931965
Molecular mechanisms for the hypoxiadependent activation of 3-amino-1, 2, 4-benzotriazine-1, 4-dioxide (SR 4233)
K Laderoute, P Wardman, AM Rauth
Biochemical pharmacology 37 (8), 1487-1495, 1988
1841988
Bioreductive therapies: an overview of drugs and their mechanisms of action
AM Rauth, T Melo, V Misra
International Journal of Radiation Oncology* Biology* Physics 42 (4), 755-762, 1998
1491998
An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions
JE Thomson, AM Rauth
Radiation Research 58 (2), 262-276, 1974
1481974
Design of Hybrid MnO2‐Polymer‐Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment
CR Gordijo, AZ Abbasi, MA Amini, HY Lip, A Maeda, P Cai, PJ O'Brien, ...
Advanced Functional Materials 25 (12), 1858-1872, 2015
1452015
Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo
AM Rauth, JK Mohindra, IF Tannock
Cancer research 43 (9), 4154-4158, 1983
1431983
The energy loss of electrons in solids
AM Rauth, JA Simpson
Radiation Research 22 (4), 643-661, 1964
1331964
In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia
JR Ballinger, JWM Kee, AM Rauth
Journal of Nuclear Medicine 37 (6), 1023-1031, 1996
1251996
The interaction of caffeine with ultra-violet-light-irradiated DNA
M Domon, B Barton, A Porte, AM Rauth
International Journal of Radiation Biology and Related Studies in Physics …, 1970
1241970
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model
HL Wong, AM Rauth, R Bendayan, XY Wu
European journal of pharmaceutics and biopharmaceutics 65 (3), 300-308, 2007
1232007
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
AJ Shuhendler, RY Cheung, J Manias, A Connor, AM Rauth, XY Wu
Breast cancer research and treatment 119 (2), 255-269, 2010
1202010
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20